Japan research team discovers new gut bacterium that boosts cancer immunotherapy
Cancer immunotherapy leverages the body's immune system to attack cancer cells. One class of drugs, known as immune checkpoint inhibitors -- including PD-1 inhibitors such as Opdivo -- works by releasing the "brakes" that cancer uses to evade immune cell attacks, thereby restoring the immune system's natural ability to target tumors.
However, even when used in combination with other treatments, checkpoint inhibitors are effective in only about 20% of patients over the long term. Previous studies have shown that transplanting stool from patients who responded well to these drugs into non-responders can improve outcomes, suggesting that gut bacteria play a key role. Until now, the mechanism by which gut bacteria influence cancers located far from the intestines, such as in the lungs, was not well understood.
The research team found that patients who responded well to immunotherapy had high levels of a type of gut bacterium from the Ruminococcaceae family. These patients experienced longer-lasting treatment effects and had more T cells -- immune cells that attack cancer -- present within their tumors.
The team identified this bacterium as a new strain, named YB328. In mouse experiments, administering both checkpoint inhibitors and YB328 led to tumor shrinkage, and even when YB328 was given together with stool transplanted from non-responders, the drug's effectiveness improved.
Further investigation revealed that YB328 activates dendritic cells -- immune system "commanders" that orchestrate immune responses -- in the gut. These dendritic cells then travel from the intestines to distant tumor sites, where they activate nearby T cells and enhance the immune attack on cancer.
Hiroyoshi Nishikawa, head of the Cancer Immunology division at the National Cancer Center Research Institute, commented, "Not only could administering this bacterium to (drug) non-responders improve outcomes, but adding it to responders' treatment regimens may further boost effectiveness."
https://doi.org/10.1038/s41586-025-09249-8
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
a day ago
Japanese Doctor Picked for U.N. Panel on Nuclear War Impact
News from Japan World Jul 19, 2025 16:47 (JST) New York, July 19 (Jiji Press)--U.N. Secretary-General Antonio Guterres has appointed 21 experts, including Japanese doctor Masao Tomonaga, who survived the 1945 U.S. atomic bombing of the southwestern Japan city of Nagasaki, as members of a panel to examine the possible impact of a nuclear war. The independent panel was set up based on a resolution adopted by the U.N. General Assembly in December last year. It consists of specialists in various fields, including nuclear and radiation studies, climate, environment, medicine and agriculture. It will examine the effects of a nuclear war on public health, ecosystems and global socioeconomic systems at both regional and global levels. The panel is set to hold its first meeting in September and submit a report to the U.N. General Assembly in 2027. The United Nations conducted a similar study in 1988. [Copyright The Jiji Press, Ltd.] Jiji Press
Yomiuri Shimbun
2 days ago
- Yomiuri Shimbun
Japanese Businesses Expanding Space-Related Operations; Government Making Plans to Increase Public Support
An increasing number of companies in Japan are making efforts to strengthen their operations related to outer space. This striking trend includes automakers, banks and other businesses with no prior connections to space. Startups are also joining the field one after another. However, competition is increasingly fierce, and for now the United States and China are the frontrunners. Japanese companies in the field will not flourish without cooperation between the public and private sectors. New possibilities In June, Honda Motor Co. became the first private company in Japan to successfully launch and land a reusable small rocket. To do this, the company used technology it had cultivated for projects such as developing self-driving vehicles. Honda R&D Co., a subsidiary of the automaker, was in charge of research and development of the reusable rocket. In an address given in Tokyo on July 8, Honda R&D President Keiji Otsu said emphatically, 'Space is a place of new possibilities.' Major companies in such fields as telecommunications and financial services are enhancing their space-related operations, and a growing number of startups are entering the field. According to research by the Spacetide Foundation, a general incorporated entity for promotion of space development, the number of startups in the space development field in 2025 was 109, an increase of about 40% from three years ago. ¥260 trillion market With space being used more and more in fields such as national security and telecommunications, related industries are expected to grow rapidly. The global market size for space businesses is predicted to exceed ¥260 trillion in 2035, about triple what it was in 2023. According to the Cabinet Office, the number of rocket launches conducted by the United States in 2024 was 153, while China had 66, putting those two countries at the head of the pack for use of space-related technology. Japan conducted only five launches last year. Many of the American rocket launches were for commercial purposes, as more than half were made by Elon Musk's company SpaceX, which uses reusable rockets to minimize costs. Cost and speed vital One issue that Japanese companies face is the high cost of conducting rocket launches. Mitsubishi Heavy Industries Ltd. aims to bring the cost of launching a rocket down to about ¥5 billion — half what it has been up to now — with its new primary rocket model, the H3, which it developed in cooperation with the Japan Aerospace Exploration Agency. The government's Basic Policy on Economic and Fiscal Management and Reform, approved by the Cabinet in June, stipulates that the nation's space development policies should be enhanced. It sets a goal of boosting the size of the domestic market to ¥8 trillion in the first half of the 2030s, double what it was in 2020. A senior official of an economy-related government entity pointed out that victory in space development goes to whoever is fastest. Thus whether Japan wins or loses in this field will come down to the speed at which projects can be commercialized. Spacetide's Representative Director Masayasu Ishida said, 'Many countries all over the world, not just the major ones, are trying to cultivate space-related industries. It is essential also for Japan to stimulate demand and acquire human resources, technologies and investment.'
2 days ago
Japan Emperor Emeritus Found with Another Heart Disorder
News from Japan Society Jul 18, 2025 19:33 (JST) Tokyo, July 18 (Jiji Press)--Japan's Emperor Emeritus Akihito was confirmed Friday to be suffering from supraventricular arrhythmia, according to an aide. The 91-year-old former Emperor was discharged from the University of Tokyo Hospital the same day, after he began receiving an additional oral treatment for his heart during his hospitalization. He will refrain from exercise that puts heavy burdens on the heart, such as using stairs. Emperor Emeritus Akihito, accompanied by Empress Emerita Michiko, 90, left the hospital in Tokyo's Bunkyo Ward by car around 11:30 a.m. and returned to the Sento Imperial Residence in the Japanese capital's Minato Ward. He began taking the oral medication to ease the load on his heart from asymptomatic myocardial ischemia, which was identified this May. The treatment did not cause side effects such as bradycardia or arrhythmia. [Copyright The Jiji Press, Ltd.] Jiji Press
